Page 2 - Volume13_Issue3
P. 2
VOLUME 13 | ISSUE 3 Pharmacists Optimizing Cancer Care
HOPA Publications Committee COLUMNS
Ashley Glode, PharmD BCOP, Chair 3 Feature
Megan Bodge, PharmD BCOP, Vice Chair
Edward Li, PharmD, Board Liaison The Cancer Moonshot Initiative
Brandi Anders, PharmD BCOP
Morgan Belling, PharmD 5 Personal Impact and Growth Reflection
Megan Brafford May, PharmD BCOP
Lisa M. Cordes, PharmD BCOP BCACP Motivation to Fight
Morgan Culver, PharmD BCOP
Craig W. Freyer, PharmD BCOP 6 The Resident’s Cubicle
Marc Geirnaert, BSc Pharm
Carolyn Oxencis, PharmD BCOP BCPS Advice for Staying Up to Date with the Literature
Christan M. Thomas, PharmD BCOP
Sarah Ussery, PharmD BCOP 8 Clinical Pearls
HOPA News Staff Cytokine Release Syndrome in Patients Receiving
Blinatumomab or Chimeric Antigen Receptor T Cells for
Elizabeth Sherman, Director of Marketing Acute Lymphoblastic Leukemia
and Communications
Kelly Kellermann, Managing Editor 12 Treatment Insights
Adrian Villegas, Graphic Designer
Protecting Access to Treatment: Opioid Therapy
HOPA News Advertising Opportunities for Cancer-Related Pain
Contact Julie Ichiba at jichiba@connect2amc.com
14 Practice Management
Send administrative correspondence or letters to
the editor to HOPA, 8735 W. Higgins Road, Suite 300, The Challenges of Drug Shortages
Chicago, IL 60631, fax 847.375.6497, or e-mail
info@hoparx.org. HOPA News is published by the 16 International Member Update
Hematology/Oncology Pharmacy Association.
© 2016 by the Hematology/Oncology Pharmacy Expanding Oncology Pharmacy on a Global Level
Association
18 Legislative News
2 20 Highlights of Member Research
22 Board Update
HOPA’s Seat “at the Table”